Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01875237 · OUTCOME

Number of Participants Assessed Post Donor Lymphocyte Infusion (DLI): Disease-free Survival & Non-relapse Mortality, Chimerism and GVHD.

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene · Source last updated 2019-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
6 months

What was measured

Participants to assess at 6 months post donor lymphocyte infusion (DLI): disease-free survival \& non-relapse mortality, chimerism and GVHD

Analysis population: Transplant only participants did not receive DLI.

Groups in this outcome

Transplant Only

Patients who did not move forward to DLI

Transplat Plus DLI

Proceeded to DLI per protocol and developed GVHD

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Transplant Only0
Transplat Plus DLI1

Reported measurements

disease-free survivaI
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Transplant Only0Not reportedNot reportedNot reportedNot reported
Transplat Plus DLI1Not reportedNot reportedNot reportedNot reported
chimerism post DLI
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Transplant Only0Not reportedNot reportedNot reportedNot reported
Transplat Plus DLI1Not reportedNot reportedNot reportedNot reported
GVHD post DLI
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Transplant Only0Not reportedNot reportedNot reportedNot reported
Transplat Plus DLI1Not reportedNot reportedNot reportedNot reported
non-relapse mortality
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Transplant Only0Not reportedNot reportedNot reportedNot reported
Transplat Plus DLI0Not reportedNot reportedNot reportedNot reported
Complete source fields
calculate Pct
false
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
    title
    disease-free survivaI
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
    title
    chimerism post DLI
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
    title
    GVHD post DLI
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
    title
    non-relapse mortality
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      1
    units
    Participants
description
Participants to assess at 6 months post donor lymphocyte infusion (DLI): disease-free survival \& non-relapse mortality, chimerism and GVHD
groups
  1. description
    Patients who did not move forward to DLI
    id
    OG000
    title
    Transplant Only
  2. description
    Proceeded to DLI per protocol and developed GVHD
    id
    OG001
    title
    Transplat Plus DLI
param Type
COUNT_OF_PARTICIPANTS
population Description
Transplant only participants did not receive DLI.
reporting Status
POSTED
time Frame
6 months
title
Number of Participants Assessed Post Donor Lymphocyte Infusion (DLI): Disease-free Survival & Non-relapse Mortality, Chimerism and GVHD.
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice